Mr. Hamed Shahbazi reports

HEALWELL UNVEILS STRATEGIC CHANGES TO EXECUTIVE LEADERSHIP TEAM TO DRIVE THE NEXT PHASE OF INTEGRATION, GROWTH AND SHAREHOLDER VALUE CREATION

Healwell AI Inc. has made a number of key executive appointments to the company's senior leadership team to reflect Healwell's focus on building a high-impact leadership team to guide the company as it shifts to its next phase of growth, scaling its world-class AI (artificial intelligence) technology and health data interoperability capabilities to become a global leader in health care technology and artificial intelligence.

Hamed Shahbazi, chairman of Healwell, commented: "After a period of intense M&A [merger and acquisition] activity, Healwell is entering into a new phase of growth. The acquisition of Orion Health presents a number of significant and timely market opportunities for the company. The Healwell Board of directors has undertaken to expand the company's executive function to ensure the company can execute on its objective of integrating its units and delivering a more holistic customer offering to meet the burgeoning demand for AI and health care data operability globally. To that end, we're very excited to appoint Mr. James Lee, a proven leader, as the new CEO of Healwell. James will work very closely with Dr. Alexander Dobranowski, who will transition to the role of president and continue to drive critical leadership functions for the company. James and Alex will be well supported by the new executive appointment of Sacha Gera as chief operating officer and the recent appointment of Brad Porter as chief commercial officer. We'd like to extend a very warm welcome to James, Sacha and Brad to the team and thank Alex for all his hard work over the past 18 months as he steps into his new role as president of the company. We have an outstanding team that is ready to take Healwell to the next level."

Highlights:

• Mr. Lee will step into the role of chief executive officer, effective July 1, 2025, to lead the transformation of Healwell into an integrated and connected business focused on redefining preventive health care with the use of data science and artificial intelligence. Mr. Lee joined Healwell in January, 2025, as chief strategy officer, where he has been preparing the company's integration strategy.
• Dr. Dobranowski will transition to president of the company and continue to be a member of the board of directors. He will be increasingly focused on the acceleration of the company's AI and data science solutions with large enterprise customers in the life sciences sector as well as continue to lead the company's capital markets activities. Under the leadership of Dr. Dobranowski, Healwell experienced unprecedented growth, completed six strategic acquisitions and raised over $100-million in capital. Dr. Dobranowski has been with Healwell since its inception, leading the company through its rapid expansion.
• Mr. Gera has been appointed chief operating officer of Healwell. In addition to overseeing day-to-day operations, Mr. Gera will also be responsible for setting and executing the company's technology strategy, integrating all aspects of the business and driving organizational alignment across Healwell's various divisions to ensure cohesive and efficient execution of the company's strategy.
• Mr. Porter, currently chief executive officer at Orion Health, has also recently taken on the role of chief commercial officer of the company, given the significant and larger-than-anticipated revenue opportunities across the combined Healwell and Orion Health platforms. Mr. Porter will retain his duties at Orion Health while helping drive Healwell's revenue growth and global commercialization strategy. In this critical role, Mr. Porter will also be responsible for distribution of Healwell's AI capabilities across the Orion Health network, with a strong focus on public-sector opportunities and government contracts.

Mr. Lee, the incoming CEO of Healwell, commented: "I am thrilled to be joining Healwell at such a pivotal moment in the company's journey. The Healwell leadership team has built a remarkable company driven by purpose, fuelled by innovation and ready to lead a global transformation in health care artificial intelligence. Now, as we step into a new phase of growth, our strategic focus is on integration, execution, and unlocking the full global potential of our AI and health care data solutions. In the short time since closing the Orion Health acquisition, we have already begun pursuing high-impact opportunities as a unified platform; and, with the strengthening of our executive team, we are aligning the company to capture what we now believe are even greater opportunities than originally anticipated. I am excited to work with a team so deeply committed to its mission of transforming health care delivery and improving patient outcomes and look forward to leading Healwell into a new era of growth and global scale."

Dr. Dobranowski, president of Healwell, commented: "Healwell has undergone massive growth since its inception, and I am immensely proud of what we've achieved. Healwell is entering an exciting new chapter in which I am excited to work alongside and support our new CEO, James Lee, to guide the company through its next stage of transformational growth. I look forward to working closely with our new team as we continue to push the boundaries of what's possible in health care. I'd like to sincerely thank Adam Hutton and Paulo Gomes, our previous co-COOs, who are leaving the organization to pursue other opportunities, for their unwavering dedication and contributions in getting us to where we are today and for laying the strong foundation upon which we will continue to build upon."

Mr. Lee -- CEO

Mr. Lee brings over two decades of experience leading large-scale multinational enterprises in financial services with deep experience in strategic growth and capital allocation to his role as CEO of Healwell. Prior to joining Healwell, Mr. Lee served as CEO of Jarden New Zealand, where he played a pivotal role in expanding the firm's investment banking footprint and delivering record-breaking growth across capital markets. Under Mr. Lee's leadership, Jarden emerged as one of New Zealand's leading financial institutions, experiencing significant growth in market share and executing some of Australasia's most high-profile transactions. Mr. Lee led Jarden through a period of rapid transformation, expanding its services across Australasia, including a full brand and cultural evolution.

In addition to his role at Jarden, Mr. Lee has held senior positions in banking and has been a strategic adviser to various start-ups and boards. He is known for his ability to navigate complex markets, foster high-performing teams and drive innovation across traditional sectors. His cross-industry experience positions him uniquely to lead the intersection of health care and technology by combining both a sense of purpose with the needs of the capital markets. Mr. Lee holds a degree in commerce and is widely recognized for his collaborative leadership style and sharp strategic vision.

Mr. Gera -- COO

Mr. Gera is a seasoned C-level executive, board member and entrepreneur renowned for driving innovation, global scalability and profitable recurring revenue growth across SaaS (software as a service), AI, cybersecurity and telecommunications/ICT (information and communications technology). His extensive leadership experience includes serving as former CEO of JSI, co-founder and president of Kandy Communications, and president of Calian Group's IT (information technology) and cybersecurity business unit. Currently, Mr. Gera contributes his expertise as a board member for Exfo and the Ottawa Board of Trade.

Recognized with the 2024 NetIP Leadership Award for professionalism, philanthropy, community work and leadership as well as the 2019 Forty Under 40 award by the OBJ, Mr. Gera holds an MBA from the Ivey School of Business and a bachelor of computer systems engineering from Carleton University.

Mr. Porter -- chief commercial officer and CEO of Orion

Mr. Porter, CEO of Orion Health, brings over 15 years of experience in finance, commercial leadership and global health care technology. A chartered accountant by training, he began his career at KPMG before moving to London, where he held investment and advisory roles with Coller Capital and Kinetic Partners. He later returned to New Zealand to join Fisher & Paykel Healthcare.

At Fisher & Paykel Healthcare, Mr. Porter held senior commercial roles, including serving as general manager, commercial (international sales), where he helped lead a 1,500-person global sales organization distributing to over 100 countries. During his tenure, the company's revenue grew from $815-million (New Zealand) to nearly $2-billion (New Zealand) and the company's direct international footprint expanded from 30 to more than 50 countries. These experiences deepened his expertise in global health care operations, commercial execution and strategic leadership.

Mr. Porter was appointed CEO of Orion Health in 2022, where he has overseen a renewed focus on innovation in health data platforms, patient engagement and readiness for AI-enabled care. He will continue in this role while also serving as chief commercial officer of Healwell, where he will be responsible for group-wide commercial strategy, revenue growth and go-to-market alignment across the organization's portfolio of companies.

About Healwell AI Inc.

Healwell is a health care artificial intelligence company focused on preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practices and ultimately help improve patient health outcomes. Healwell is executing a strategy centred around developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the OTC (over-the-counter) exchange under the symbol HWAIF.

We seek Safe Harbor.